These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 29472602)

  • 41. Human papillomavirus and disease mechanisms: relevance to oral and cervical cancers.
    Nair S; Pillai MR
    Oral Dis; 2005 Nov; 11(6):350-9. PubMed ID: 16269025
    [TBL] [Abstract][Full Text] [Related]  

  • 42.
    Chu M; Zhou M; Jiang C; Chen X; Guo L; Zhang M; Chu Z; Wang Y
    Front Immunol; 2018; 9():862. PubMed ID: 29922279
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Comprehensive analysis of lncRNAs microarray profile and mRNA-lncRNA co-expression in oncogenic HPV-positive cervical cancer cell lines.
    Yang L; Yi K; Wang H; Zhao Y; Xi M
    Oncotarget; 2016 Aug; 7(31):49917-49929. PubMed ID: 27363024
    [TBL] [Abstract][Full Text] [Related]  

  • 44. From HPV Infection to Lesion Progression: The Role of HLA Alleles and Host Immunity.
    Paaso A; Jaakola A; Syrjänen S; Louvanto K
    Acta Cytol; 2019; 63(2):148-158. PubMed ID: 30783048
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Antisense targeting human papillomavirus type 16 E6 and E7 genes contributes to apoptosis and senescence in SiHa cervical carcinoma cells.
    Sima N; Wang S; Wang W; Kong D; Xu Q; Tian X; Luo A; Zhou J; Xu G; Meng L; Lu Y; Ma D
    Gynecol Oncol; 2007 Aug; 106(2):299-304. PubMed ID: 17586029
    [TBL] [Abstract][Full Text] [Related]  

  • 46. MAML1 regulates cell viability via the NF-κB pathway in cervical cancer cell lines.
    Kuncharin Y; Sangphech N; Kueanjinda P; Bhattarakosol P; Palaga T
    Exp Cell Res; 2011 Aug; 317(13):1830-40. PubMed ID: 21640102
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Bacterial lipopolysaccharide induces increased expression of toll-like receptor (TLR) 4 and downstream TLR signaling molecules in bovine mammary epithelial cells.
    Ibeagha-Awemu EM; Lee JW; Ibeagha AE; Bannerman DD; Paape MJ; Zhao X
    Vet Res; 2008; 39(2):11. PubMed ID: 18096120
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Global expression analysis in uterine cervical cancer: metabolic pathways and altered genes].
    Vázquez-Ortíz G; Piña-Sanchez P; Hidalgo A; Lazos M; Moreno J; Alvarado I; Cruz F; Hernández DM; Pérez-Plascencia C; Salcedo M
    Rev Invest Clin; 2005; 57(3):434-41. PubMed ID: 16187704
    [TBL] [Abstract][Full Text] [Related]  

  • 49. HPV: Molecular pathways and targets.
    Gupta S; Kumar P; Das BC
    Curr Probl Cancer; 2018; 42(2):161-174. PubMed ID: 29706467
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Specific down-modulation of Notch1 signaling in cervical cancer cells is required for sustained HPV-E6/E7 expression and late steps of malignant transformation.
    Talora C; Sgroi DC; Crum CP; Dotto GP
    Genes Dev; 2002 Sep; 16(17):2252-63. PubMed ID: 12208848
    [TBL] [Abstract][Full Text] [Related]  

  • 51. HMGB1 signals through toll-like receptor (TLR) 4 and TLR2.
    Yu M; Wang H; Ding A; Golenbock DT; Latz E; Czura CJ; Fenton MJ; Tracey KJ; Yang H
    Shock; 2006 Aug; 26(2):174-9. PubMed ID: 16878026
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The functional role of Notch signaling in HPV-mediated transformation is dose-dependent and linked to AP-1 alterations.
    Henken FE; De-Castro Arce J; Rösl F; Bosch L; Meijer CJ; Snijders PJ; Steenbergen RD
    Cell Oncol (Dordr); 2012 Apr; 35(2):77-84. PubMed ID: 22271085
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The HPV viral regulatory mechanism of TLRs and the related treatments for HPV-associated cancers.
    Qi SY; Yang MM; Li CY; Yu K; Deng SL
    Front Immunol; 2024; 15():1407649. PubMed ID: 38812510
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Innate immunity and HPV: friends or foes.
    Nunes RAL; Morale MG; Silva GÁF; Villa LL; Termini L
    Clinics (Sao Paulo); 2018 Oct; 73(suppl 1):e549s. PubMed ID: 30328949
    [TBL] [Abstract][Full Text] [Related]  

  • 55. TLR4: An Important Molecule Participating in Either Anti-Human Papillomavirus Immune Responses or Development of Its Related Cancers.
    Bahramabadi R; Dabiri S; Iranpour M; Kazemi Arababadi M
    Viral Immunol; 2019 Dec; 32(10):417-423. PubMed ID: 31721657
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Molecular classification of human papillomavirus-positive cervical cancers based on immune signature enrichment.
    Song G; Luo J; Zou S; Lou F; Zhang T; Zhu X; Yang J; Wang X
    Front Public Health; 2022; 10():979933. PubMed ID: 36203656
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Sarm1/Myd88-5 Regulates Neuronal Intrinsic Immune Response to Traumatic Axonal Injuries.
    Wang Q; Zhang S; Liu T; Wang H; Liu K; Wang Q; Zeng W
    Cell Rep; 2018 Apr; 23(3):716-724. PubMed ID: 29669278
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Passenger Mutations Confound Phenotypes of SARM1-Deficient Mice.
    Uccellini MB; Bardina SV; Sánchez-Aparicio MT; White KM; Hou YJ; Lim JK; García-Sastre A
    Cell Rep; 2020 Apr; 31(1):107498. PubMed ID: 32268088
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Circular RNAs and cervical cancer: friends or foes? A landscape on circRNA-mediated regulation of key signaling pathways involved in the onset and progression of HPV-related cervical neoplasms.
    Heydarnia E; Dorostgou Z; Hedayati N; Mousavi V; Yahyazadeh S; Alimohammadi M; Gheibi M; Heidari P; Igder S; Mafi A; Vakili O
    Cell Commun Signal; 2024 Feb; 22(1):107. PubMed ID: 38341592
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The immune response to papillomavirus during infection persistence and regression.
    Hibma MH
    Open Virol J; 2012; 6():241-8. PubMed ID: 23341859
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.